Stockhub

CohBar, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

2 September 2022

  • curprev 06:1206:12, 2 September 2022 95.149.241.133 talk 972 bytes +972 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alz..."
Retrieved from "https://stockhub.co/research/CohBar,_Inc."